R-Chop clinical trials
R-Chop is named as an intervention in 19 current clinical trials in our China, Italy, Japan, UK, USA, India, Germany, France, Spain, Belgium, Sweden, Denmark, Poland, Czechia, Turkey, Canada, Brazil, South Korea, Taiwan and Australia registers. 11 are recruiting patients now. The most common phase is Phase 2. The sponsor with the most trials is Sun Yat-sen University (6). The most-studied condition is DLBCL - Diffuse Large B Cell Lymphoma.
Patient leaflets for R-Chop
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of R-Chop
19 trialsRegisters list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with R-Chop
21 conditionsAll 21 conditions
| Condition (as registered) | Trials |
|---|---|
| DLBCL - Diffuse Large B Cell Lymphoma | 4 |
| Diffuse Large B Cell Lymphoma (DLBCL) | 3 |
| R-CHOP Chemotherapy | 2 |
| Diffuse Large B-Cell Lymphoma | 2 |
| Diffuse Large B Cell Lymphoma | 2 |
| Untreated Follicular Lymphoma | 1 |
| TP53 | 1 |
| Pirtobrutinib | 1 |
| Diffuse Large B-Cell Lymphoma (DLBCL) | 1 |
| CD5 Positive | 1 |
| BTK Inhibitors | 1 |
| Histone Deacetylase Inhibitor | 1 |
| Double Express Diffuse Large B-cell Lymphoma | 1 |
| Lymphoma, Large-Cell, Diffuse | 1 |
| Chidamide | 1 |
| Double-expressor Lymphoma (DEL) | 1 |
| The First Affiliated Hospital of Nanchang University | 1 |
| DLBCL | 1 |
| Follicular Lymphoma | 1 |
| Non Hodgkins Lymphoma | 1 |
| Diffuse Large B-cell Lymphoma | 1 |
Sponsors
lead sponsor per trialBy country register
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about R-Chop trials
How many clinical trials are testing R-Chop?
19 current trials in our China, Italy, Japan, UK, USA, India, Germany, France, Spain, Belgium, Sweden, Denmark, Poland, Czechia, Turkey, Canada, Brazil, South Korea, Taiwan and Australia registers name R-Chop as a drug or biological intervention, as of the registry sync on 9 November 2026. Completed and withdrawn studies are not counted.
Are R-Chop trials recruiting patients?
Yes. 11 of the 19 trials are recruiting: 11 with sites in China, 1 with sites in Italy, 1 with sites in Japan, 1 with sites in UK, 1 with sites in USA, 1 with sites in India, 1 with sites in Germany, 1 with sites in France, 1 with sites in Spain, 1 with sites in Belgium, 1 with sites in Sweden, 1 with sites in Denmark, 1 with sites in Poland, 1 with sites in Czechia, 1 with sites in Turkey, 1 with sites in Canada, 1 with sites in Brazil, 1 with sites in South Korea, 1 with sites in Taiwan and 1 with sites in Australia. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors R-Chop clinical trials?
Sun Yat-sen University (6), The First Affiliated Hospital with Nanjing Medical University (2), AstraZeneca (1) and Ou Bai, MD/PHD (1), among 13 lead sponsors in total. The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how R-Chop works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how R-Chop works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists R-Chop (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 9 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.